The Patent Finder
US

Use of ANTI-CS1 Antibodies for Treatment of Rare Lymphomas

US 8,603,477 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Facet Biotech Corporation, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Feb 24, 2030 · High confidence

Filed Apr 28, 2011 as application 13/126,754 · Granted Dec 10, 2013
Base term plus 118 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2009 2030
Clock starts
Oct 29, 2009
Term ends
Feb 24, 2030
Granted
Dec 10, 2013
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
118
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 118 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 29, 2009, when application PCT/US2009/062648, the earliest non-provisional in its chain, was filed (this one was filed Apr 28, 2011)Oct 29, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+118 days, USPTO patent term adjustment recordFeb 24, 2030High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 24, 2030High confidence

This family

US 8,603,477this patent
Feb 2030
Feb 2030
1 of 2 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 18, 2013
Reel 29825, frame 70
Abbott Biotherapeutics Corp.AbbVie Biotherapeutics Inc.Change of Name
Sep 5, 2013
Reel 31144, frame 351
Afar, DanielPDL Biopharma, Inc.Assignment of Assignor's Interest
Sep 5, 2013
Reel 31144, frame 829
PDL Biopharma, Inc.Facet Biotech CorporationAssignment of Assignor's Interest
Sep 5, 2013
Reel 31145, frame 193
Afar, DanielFacet Biotech CorporationAssignment of Assignor's Interest
Sep 5, 2013
Reel 31170, frame 83
Hsi, EricThe Cleveland ClinicAssignment of Assignor's Interest
Sep 5, 2013
Reel 31169, frame 958
Facet Biotech CorporationAbbott Biotherapeutics Corp.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited